Crocs heads into its Q1 2026 earnings report with a notable shift in analyst sentiment colliding with a still-meaningful short position — and the two are pulling in opposite directions.
The analyst story is the most interesting development ahead of the print. Baird upgraded the stock to Outperform this morning, lifting its target from $115 to $150 — a move that lands on the day of the earnings release itself and signals conviction rather than caution. Bank of America raised its target to $145 earlier in the week while holding its Buy rating. The direction of travel is clear: targets across the board have been moving higher since the Q4 print in February, and the consensus has climbed well above where most neutral-to-bearish analysts were anchored just three months ago. Goldman Sachs, still rated Sell with a $81 target, is the notable outlier — the stock closed at $120.65, meaning the firm is already deeply offside if the recent 16% monthly rally holds.
The bull case rests on North America momentum, the turnaround narrative around Hey Dude, and a valuation that remains genuinely cheap for a consumer brand: the forward P/E is running near 8.5x and EV/EBITDA near 7.5x. Bears point to the drag from Hey Dude underperformance, potential tariff and cost headwinds, and consumer spending uncertainty that could pressure the wholesale channel. The consensus is a lukewarm hold — five buys, eight holds — but the recent flurry of upgrades and target raises suggests the Street is warming up. The mean target of $117.25 now sits slightly below the current price, though the Baird and BofA moves push the upper end of active bulls to the $145-$150 range.
Short positioning complicates the picture. Nearly 10% of the free float is sold short — a genuinely elevated level for a consumer brand — and that position grew roughly 11% over the past month. It did ease about 7% on the week, though, suggesting some covering into the run-up. Borrow conditions offer no particular tension: cost to borrow is a modest 0.52%, and availability is ample at 302%, well below the year's tightest levels. The ORTEX short score has drifted lower over the past week to 59.6 from a recent peak near 63, consistent with short sellers reducing rather than adding risk into the print.
Options positioning reads as broadly neutral. The put/call ratio is 0.81, almost exactly in line with its 20-day average, with a z-score near zero. There is no unusual hedging demand, no aggressive call-buying — the options market is not expressing a strong directional view either way. The last two earnings prints produced modest positive moves, with the stock rising roughly 3.7% on the day and holding those gains over the following week. The February 2026 print was the outlier, delivering a 17% single-day gain. The question this print will test is whether the re-rating in analyst sentiment — and the stock's 16% surge this month — is justified by actual improvement in Hey Dude and North America revenue, or whether the bar has simply moved too high to clear cleanly.
See the live data behind this article on ORTEX.
Open CROX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
